Loading...
NPI 1821029760 · Las Vegas, NV · Pain Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Franco Lee is a pain medicine physician provider located in Las Vegas, Nevada. This profile covers 25 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Franco Lee |
| Address | 5741 S Fort Apache Rd Ste 120 |
| City | Las Vegas |
| State | NV |
| ZIP | 89148 |
| Taxonomy | Pain Medicine Physician |
| NPI Enumerated | July 6, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $212.2K |
| Medicaid | $44.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 800 | $60 | $50.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 340 | $90 | $30.6K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 40 | $510 | $20K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 4,600 | $1 | $18.4K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 60 | $260 | $16.8K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 80 | $150 | $11.6K |
| 64636 | In this add on procedure, the provider destroys the facet joint nerve of a lumbar or sacral spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 40 | $290 | $11.2K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 50 | $200 | $9.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 120 | $60 | $7.2K |
| 64633 | In this procedure, the provider destroys the facet joint nerve of a cervical or thoracic spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 10 | $500 | $7K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0481 | 13 | 20 | 130 | $150 | $74.5K |
| 64635 | 36 | 80 | 40 | $440 | $25.2K |
| 80307 | 50 | 110 | 100 | $60 | $21.9K |
| 64483 | 38 | 100 | 60 | $230 | $20.3K |
| 99214 | 754 | 3,610 | 110 | $80 | $19K |
| 64493 | 61 | 80 | 50 | $210 | $17.1K |
| 64633 | 30 | 30 | 30 | $450 | $16.2K |
| 62323 | 29 | 70 | 40 | $190 | $10.2K |
| 99213 | 128 | 3,500 | 80 | $60 | $10K |
| J3300 | 2 | 10 | 3,180 | $1 | $9.8K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 680 | $60 | $42.3K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 30 | $100 | $2.6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 60 | $1 | $120 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 60 | $1 | $60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 40 | $1 | $40 |
How this provider's Medicaid billing volume and revenue compare to other Nevada providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nevada median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 878 | 2,480 | 330 | $50 | $107.6K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 636 | 860 | 100 | $70 | $42.9K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 37 | 40 | 1,790 | $1 | $1.4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 104 | 150 | 180 | $1 | $1.4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 36 | 40 | 1,510 | $1 | $370 |
Other providers in the same ZIP code as Franco Lee, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.